Page 2 - Accurium News Today

Investegate announcements from Curium, Curium’s 14 Million Patients to Benefit From Regular Supply of Mo-99 and Tc-99

Forecast of no further supply chain challenges for nuclear medicine industry...

Additional production runs and increased processing for the benefit of patientsPARIS, Nov. 23, 2022 (GLOBE NEWSWIRE) -- Curium, the world's leading nuclear medicine company, announced today that with the

Investegate announcements from Curium, Curium’s Customers to Benefit From Mo-99 Production Restart

ST. LOUIS, Nov. 22, 2022 (GLOBE NEWSWIRE) -- Curium, the world's leading nuclear medicine company, announced today that it intends to submit updated labeling to the U.S. Food and Drug Administration (FDA)

Investegate announcements from Curium, Nuclear Medicine Outlook: Proven Molybdenum-99 Supply Chain Reliability and New Planned Capacity Continue to Benefit Patients

A robust supply chain for the future despite near-term shortagesMeasures in place minimize impact of near-term molybdenum-99 shortageMore than ten years of Mo-99 supply chain resilienceCooperation, investment

SMSF services provider Accurium is expanding its education offering beyond SMSF technical content into personal and small business taxation and broader tax planning strategies. In a recent online blo

Investegate announcements from Curium, Curium Confirms No Supply Challenges of 177Lu-PSMA-I&T for ECLIPSE Trial

Local charities and participants in the platinum jubilee of Queen Elizabeth II next month in Cyprus have turned their backs on the concert following political controversy linked to EOKA, as more participants are now refusing to take part ahead of an election year